Bluetongue Virus

Overview and Taxonomy of Bluetongue Virus

Bluetongue virus (BTV) is an arthropod‐borne pathogen that causes bluetongue disease in ruminants and is a major concern for animal health and international livestock trade. Classified within the genus Orbivirus of the family Reoviridae, BTV is the type species of the genus and is recognized as a non‐enveloped virus with a complex, multilayered capsid structure that encapsulates a segmented double-stranded RNA genome [1-3]. The virus is endemic in diverse geographical regions and continues to expand its epidemiological footprint, a development that has prompted significant research attention and global surveillance efforts by institutions such as the World Organisation for Animal Health (WOAH), the Food and Agriculture Organization (FAO), and national public health bodies like the CDC.

Taxonomic Classification and Genome Organization

BTV is taxonomically distinguished by its segmented dsRNA genome consisting of 10 unique segments that encode both structural and non-structural proteins. The outer capsid protein VP2, encoded by genome segment 2, is the most variable among these proteins and is responsible for defining the virus serotype. This antigenic diversity underpins the existence of at least 27 distinct serotypes, classically numbered BTV-1 through BTV-24, with additional atypical serotypes such as BTV-25, BTV-26, BTV-27, and putatively novel serotypes like BTV-29 emerging from recent surveillance studies [2, 6, 7, 17]. The serotype is pivotal not only in immunological recognition but also in dictating the specificity of diagnostic assays, often targeting VP2, as well as in vaccine development, where DIVA (Differentiation of Infected from Vaccinated Animals) strategies are critical [2, 14].

The segmented nature of the BTV genome is central to its evolutionary dynamics. Reassortment events, whereby entire genome segments are exchanged between different BTV strains, have been well documented and are crucial drivers of genetic diversity and adaptation. Such processes have been implicated in outbreaks where reassortant viruses show altered pathogenicity or transmission characteristics [16]. Variations in segments can affect virulence factors, host interactions, and even the virus’s ability to replicate in vector insects or mammalian hosts [9, 18].

Molecular and Structural Characteristics

Structurally, BTV possesses a layered capsid that is key to its replication cycle and pathogenicity. The outer layer, composed predominantly of VP2 and VP5, not only mediates attachment to host cellular receptors but also plays a significant role in cell entry through mechanisms that may include both lytic and non-lytic budding processes [8]. Beneath this, the inner capsid proteins form a core that houses the RNA-dependent RNA polymerase (RdRp), which is essential for viral transcription and replication. Recent cryo-electron microscopy studies have elucidated the in situ structure of the RdRp within both the intact virion and the core structure, thereby providing insight into the controlled regulation of mRNA synthesis from the segmented genome [9].

The interplay between viral proteins and host cellular factors, such as molecular chaperones like Hsp90, further underscores the complexity of BTV’s life cycle. These interactions assist in proper protein folding and stabilization, and in turn, safeguard viral proteins from host proteasomal degradation [11]. Such host-virus interactions are critical for maintaining the integrity of viral replication complexes and may also serve as potential targets for antiviral intervention.

Host Range, Vectors, and Epidemiological Implications

BTV primarily affects ruminants, including sheep, cattle, goats, and wild ungulate populations. While the clinical manifestations range from severe hemorrhagic disease in susceptible species (notably sheep) to subclinical or mild infections in cattle and goats, the economic impact is substantial due to trade restrictions and livestock losses. Transmission occurs almost exclusively via specific species of biting midges (Culicoides spp.), which serve as biological vectors [1, 2]. However, emerging evidence indicates that some atypical serotypes can be transmitted by alternative routes, including direct contact between animals, thereby complicating the epidemiology and necessitating a revisiting of transmission models [12, 20].

Environmental factors, such as climate change and vector distribution, have profoundly influenced the epidemiology of BTV. Shifts in temperature, humidity, and vector habitat availability have been associated with the re-emergence of classical serotypes as well as with the appearance of exotic strains in regions previously considered free of the disease [4, 13, 15]. Such factors are particularly relevant to surveillance programs coordinated by authorities like WHO and FAO, which continuously update guidelines to mitigate spread in regions affected by altered vector ecologies.

The evolutionary history of BTV also reflects its long-standing association with domestic and wild ruminants. Phylogeographic studies suggest that ancestral hosts, such as goats, played an important role in the origin and dissemination of the virus, with subsequent adaptations leading to diverse topotypes and serotypes that are now distributed globally [5]. These insights into the virus’s evolutionary dynamics have significant implications for molecular surveillance, epidemiological modeling, and vaccine strategy planning, particularly in regions where multiple serotypes co-circulate and where reassortment events can lead to the emergence of novel strains with unpredictable virulence profiles.

Implications for Diagnostics and Control

Given its segmented genome and the high degree of serotype-specific variation, accurate diagnostic protocols are essential to differentiate between BTV serotypes. Molecular assays, including serotype-specific RT-PCR techniques, are widely employed for surveillance and outbreak investigations, permitting rapid and precise identification without the need for virus isolation [14, 19]. Such diagnostic strategies are endorsed by international bodies such as the WOAH and are central to implementing timely control measures. Furthermore, the taxonomic and molecular characterization of BTV is instrumental in guiding vaccine development, where recombinant and synthetic vaccine approaches are being explored to address the challenge posed by the virus’s genetic diversity [10, 21, 22].

In summary, the taxonomy of Bluetongue virus is defined by its segmented dsRNA genome, complex virion structure, and remarkable serotypic diversity. This framework underpins the virus’s adaptability, its interactions with diverse hosts and vectors, and the epidemiological challenges it presents on a global scale. Such comprehensive taxonomic and molecular insights are indispensable for the formulation of effective surveillance, diagnostic, and control strategies endorsed by global health authorities including WHO, CDC, and FAO.

Molecular Pathogenesis and Structural Biology of Bluetongue Virus

Bluetongue virus (BTV), the prototype orbivirus of the Reoviridae family, is a non-enveloped virus with a segmented double‐stranded RNA genome that has served as a model for dissecting virus–host interactions and the intricate details of viral assembly. The structure and molecular pathogenesis of BTV are central to understanding its capacity to cause economically significant disease in ruminants, a fact underscored by international health organizations such as the Centers for Disease Control and Prevention (CDC) and the World Organisation for Animal Health (WOAH).

Structural Architecture and Genome Organization

At the heart of BTV’s biology lies its distinctive multi-layered capsid. The outer capsid proteins, VP2 and VP5, not only determine serotype specificity and trigger neutralizing antibody responses but also mediate attachment and penetration into host cells. VP2, in particular, is critical as it interacts with cellular receptors and is the primary determinant for serotype classification [14]. Beneath this layer, the inner core is composed principally of VP3 and VP7, which encapsidate the 10 segmented dsRNA genome. The organization of these multiple segments is not random; rather, the virus has evolved highly selective mechanisms for RNA packaging. Recent investigations using cell-free in vitro assembly systems have demonstrated that the smallest segment, S10, plays a pivotal role in initiating packaging by triggering RNA–RNA interactions that sequentially recruit the remaining segments [25]. Furthermore, emergent studies have revealed that RNA elements within the open reading frames, beyond merely encoding proteins, are essential for the replication of BTV, thereby adding another layer of regulatory complexity [26].

The inner architecture of BTV has been further elucidated by high-resolution cryo-electron microscopy studies. Structures of the RNA-dependent RNA polymerase (RdRp) VP1 within both the intact virion and the transcriptionally active core have uncovered unique structural motifs, such as a “fingernail” subdomain and bundled helices, that are not found in other viral polymerases [9]. These fine structural details underpin the precisely regulated transcriptional activity essential for the virus’s replication cycle.

Replication Cycle and Host Interactions

Following entry, which is mediated by endocytosis triggered after receptor binding by VP2 and VP5, the outer capsid is shed to yield the inner core. This core, which remains intact in the cytoplasm, provides a controlled microenvironment for viral transcription and replication. The structural rearrangements that occur during uncoating are coupled to conformational changes in RdRp VP1, thereby priming the enzyme for mRNA synthesis. The precise orchestration of these events ensures that viral replication is both efficient and well‐regulated within the infected cell [9].

An essential facet of BTV replication is its reliance on host cell machinery along with its own finely tuned protein functions. For instance, the cellular chaperone heat shock protein 90 (Hsp90) has been demonstrated to stabilize several BTV proteins, protecting them from proteasomal degradation and thereby facilitating efficient viral assembly and propagation [11]. This interaction exemplifies the virus’s adeptness at commandeering host factors for its benefit.

Nonstructural Proteins and Pathogenesis

Beyond the structural proteins, the nonstructural proteins encoded by BTV play pivotal roles in dictating pathogenic outcomes. NS3, one of the key nonstructural proteins, is heavily implicated in the non-lytic release of virus particles. Initially considered to drive cell lysis, recent studies have shown that NS3 orchestrates a non-lytic budding process by engaging components of the host cell sorting and exocytosis pathways [8]. This alternative egress mechanism not only facilitates efficient virus spread but also minimizes damage to the host cell, enabling prolonged viral replication cycles.

Another nonstructural protein, NS4, has emerged as a critical virulence factor due to its role as an interferon antagonist. Experimental comparisons between mutant viruses lacking NS4 and wild-type viruses have revealed that NS4 downregulates the synthesis of type I interferons and interferon-stimulated genes in infected host cells [23]. By dampening the innate immune response, NS4 effectively allows BTV to evade early antiviral defenses, thereby establishing a more robust infection. In some cases, even subtle differences in NS4 function can markedly influence the clinical severity observed in infected ruminants.

Additionally, overlapping open reading frames in segment 10, which encode both NS3 and a second protein produced from an alternative reading frame, have been characterized to possess inhibitory functions on host gene expression. The localization of these proteins to the nucleolus and their ability to modulate promoter activity, without affecting mRNA splicing or general cellular translation, demonstrate an intricate level of control that BTV exerts over host cell machinery [24]. These multifunctional proteins exemplify the evolutionary ingenuity of BTV in maximizing its coding capacity within a compact genome.

Genome Packaging and Reassortment Dynamics

A defining feature of BTV, common to all segmented viruses, is genome reassortment. Reassortment events, wherein segments from different virus strains are mixed, have been documented extensively and play a central role in the evolution and epidemiology of BTV [16]. The inherent plasticity of the segmented genome allows for the emergence of novel serotypes and strains with altered virulence profiles. This dynamic reassortment leads to variations in key structural and regulatory proteins, potentially affecting host cell tropism, immune evasion abilities, and transmission characteristics. Such mechanisms have been heavily implicated in the rapid changes in BTV epidemiology observed in Europe during recent outbreaks, as well as in other regions where livestock trade and climatic influences facilitate virus spread [18].

The fidelity of genome segment assembly is underscored by recent studies that identify the sequential recruitment of viral RNAs during capsid assembly. The smallest segment, S10, acts as an initiator, with its untranslated regions being particularly critical for orchestrating the correct assembly of the complete viral genome [25]. This tightly regulated process not only ensures the incorporation of all necessary genetic information but also sets the stage for subsequent rounds of replication that define the virus’s infectious cycle.

Integration of Structural and Functional Insights

Insights from structural biology have provided an invaluable framework for understanding BTV pathogenesis at the molecular level. High-resolution analyses of the capsid assembly and transcription machinery have laid bare the interplay between specific viral proteins and host cellular factors, an interaction landscape that informs the design of novel therapeutic interventions and vaccines. The integration of these data with epidemiological findings, such as those reported by international bodies (e.g., WHO and FAO), reinforces the global health importance of monitoring and controlling BTV outbreaks.

In summary, the molecular pathogenesis and structural biology of Bluetongue virus reveal a highly orchestrated interplay of viral protein functions, genome packaging mechanisms, and host interactions. These sophisticated processes not only enable successful viral replication but also underpin the virus’s capacity for rapid evolution and immune evasion, traits that have contributed greatly to its status as a pathogen of major economic concern in the livestock industry worldwide [9, 11, 23-25].

Epidemiology and Global Distribution of Bluetongue Virus

Bluetongue virus (BTV) is a highly dynamic and genetically diverse pathogen that has dramatically expanded its geographic range over recent decades. Traditionally confined to specific regions, BTV was initially recognized in southern Africa before its emergence in Europe and subsequent incursion into North America, Asia, and other continents. Its epidemiology, closely tied to the biology of its primary vectors, Culicoides midges, and the interplay of ecological, climatic, and anthropogenic factors, has been the subject of intense research and surveillance efforts by international organizations such as the World Organisation for Animal Health (WOAH), the Centers for Disease Control and Prevention (CDC), and the Food and Agriculture Organization (FAO).

Global Emergence and Distribution

Since the late 20th century, BTV has transitioned from a geographically restricted disease to a globally distributed pathogen. In Europe, for instance, the dramatic outbreak of BTV serotype 8 in northwestern regions in 2006 marked a significant turning point, revealing that previously unexposed livestock populations were susceptible to severe clinical disease [2, 27]. More recently, the detection of BTV serotype 3 in the Netherlands in September 2023 further underscores the expanding epidemiological spectrum of the virus across European territories [27]. In parallel, studies in western Germany have documented the emergence of BTV-3 in Culicoides midge pools, illustrating the intricate association between virus circulation and vector competence in temperate regions [28].

Beyond Europe, BTV exhibits a complex pattern of distribution in Asia, where multiple serotypes co-circulate. Extensive seroprevalence studies in China have highlighted the virus’s endemicity, with meta-analyses revealing variations in prevalence influenced by livestock management practices and climatic conditions [30, 31]. India, similarly, has emerged as a hotspot for BTV diversity, harboring numerous serotypes, 23 to date, with evidence pointing toward both endemic circulation and recurrent incursions of exotic serotypes [2]. Such findings suggest that transboundary livestock trade, alongside the changing ecology of vectors, plays a pivotal role in the virus’s global dissemination.

In the Americas, investigations have confirmed the presence of multiple serotypes, particularly in the southeastern United States and in regions bordering the Caribbean. Notably, shifts in serotype distribution, such as the sporadic detection of BTV-2, have been linked to reassortment events and potential introductions from adjacent regions [36]. South America, Central America, and the Caribbean also present complex epidemiological landscapes, where surveillance data continue to reveal a mosaic of circulating serotypes, each influenced by local vector species and climatic conditions [35].

Role of Vectors and Environmental Drivers

The transmission of BTV is inextricably connected to its primary vectors, the Culicoides biting midges. Numerous studies have shown that vector biology, including species distribution, abundance, and seasonal dynamics, fundamentally shapes patterns of virus transmission. In Sardinia, for example, investigations have highlighted the significant contributions of not only the well-recognized Culicoides imicola but also other species such as those in the Newsteadi complex and Obsoletus complex in both coastal and inland areas [34]. These findings underscore that vector diversity and abundance, modulated by local ecological and climatic factors, often dictate the intensity and seasonality of outbreaks.

Environmental drivers like temperature, altitude, and wind direction further influence the dispersal of infected midges. Phylogeographic models applied to European BTV strains have revealed that factors such as terrestrial habitat below 300 meters, prevailing wind patterns, and high livestock densities are associated with accelerated rates of virus movement [13]. This observation is particularly critical in the context of climate change, which is predicted to expand the ecological niches suitable for Culicoides species, thereby facilitating BTV spread into previously unaffected regions such as central Africa, parts of the United States, and western Russia [15]. The integration of such environmental determinants into epidemiological models is essential for predicting future disease spread and optimizing intervention strategies, as recommended by global public health entities like WOAH and FAO.

Transmission Mechanisms and Reassortment Dynamics

BTV is characterized by its segmented double-stranded RNA genome, which confers the ability to reassort during co-infections. This genetic plasticity contributes not only to the diversity of serotypes but also to the emergence of new phenotypic traits that can influence virulence and transmission dynamics. Phylogenetic studies of European and global isolates have documented frequent reassortment events, with full-genome analyses showing that even closely related strains can exchange genomic segments [16]. For example, during periods of vaccine deployment or co-circulation of different serotypes, reassortment events have been implicated in altering viral fitness and vector competence [16, 33]. Such genetic exchanges can yield novel strains with distinct epidemiological characteristics, complicating surveillance and control measures.

Moreover, direct contact transmission has been noted in certain atypical serotypes, such as BTV-27 and BTV-26, where traditional vector-mediated spread might not fully explain the observed epidemiological patterns [12, 20]. These findings suggest that the virus may exploit multiple transmission modalities simultaneously, particularly in settings where vector densities are low or environmental conditions do not favor midge activity. Coupled with the capacity for rapid spread through wind-assisted dispersal, these mechanisms collectively underscore the adaptive potential of BTV in diverse ecological contexts.

Influence of Livestock Management and Surveillance

The global spread and recurrent incursions of BTV are also closely linked to livestock management and trade practices. As a notifiable disease recognized by the OIE, BTV imposes significant socio-economic consequences, prompting comprehensive surveillance programs in many countries. Studies conducted in southern Italy and China, for instance, have employed robust seroprevalence analyses to identify risk factors such as free-range farming practices, which are associated with higher exposure to infected midges [29, 30]. Such research has informed the development of targeted control strategies, including vector control measures and vaccination campaigns, which are critical for mitigating losses in livestock production.

International surveillance networks and research consortia continuously monitor the genetic evolution and geographic spread of BTV, enabling authorities to respond swiftly to emerging serotypes or novel reassortants. Notably, the integration of molecular diagnostics, such as real-time reverse transcription-polymerase chain reaction (RT-qPCR) assays, into routine diagnostic workflows has revolutionized the capacity for early detection and precise serotype identification [14, 32]. These diagnostic advances, endorsed by agencies like the CDC and WHO for monitoring economically significant animal diseases, have proven indispensable for outbreak management and the enforcement of animal movement restrictions in affected regions.

Implications for Future Outbreaks

The epidemiology of BTV illustrates a complex interplay of viral biology, vector ecology, and anthropogenic factors. Climate change, global trade, and the intrinsic capacity of BTV to undergo reassortment collectively drive its unpredictable emergence in new regions. Continued collaboration among international veterinary authorities, researchers, and public health agencies (such as WOAH, FAO, CDC, and WHO) is therefore central to developing integrated control measures that are both timely and effective. In this context, an in-depth understanding of the global distribution and epidemiological drivers of BTV remains a cornerstone for safeguarding ruminant health and ensuring economic stability in the livestock sector.

By dissecting the multi-layered factors influencing BTV spread, from vector distribution and environmental conditions to genetic reassortment and livestock management practices, researchers are gradually piecing together a comprehensive picture of this pathogen’s global dynamics. As surveillance networks and diagnostic technologies continue to evolve, so too will strategies aimed at anticipating and mitigating the impacts of future bluetongue outbreaks.

Diagnostic Strategies and Laboratory Approaches for Bluetongue Virus

The laboratory diagnosis of bluetongue virus (BTV) is multifaceted, employing a range of molecular and serological methods that are critical for early outbreak detection, epidemiological investigations, and informing control strategies as recommended by international authorities such as the World Organisation for Animal Health (WOAH) and the World Health Organization (WHO). Extensive research over recent decades has refined diagnostic methodologies, helping researchers and veterinary practitioners distinguish among multiple serotypes, investigate viral reassortment events, and monitor disease spread within susceptible ruminant populations [27, 39].

Molecular Diagnostic Assays: RT-PCR and Beyond

Molecular methods represent the cornerstone of BTV detection due to their high sensitivity and specificity. Reverse transcription polymerase chain reaction (RT-PCR) assays have become the gold standard in detecting BTV nucleic acid in clinical samples. These assays target conserved regions of viral genomic segments such as those encoding VP7 and VP2 proteins. The VP7 protein, being highly conserved among orbiviruses, is used for serogroup differentiation, whereas VP2, which exhibits pronounced variability, is the primary target for serotype-specific identification [14, 39]. Such assays are essential not only for confirming BTV infection but for typing the virus to inform vaccination strategies and monitor epidemiological shifts over time. Recent advancements have seen the development of ‘TaqMan’ fluorescence-probe based quantitative RT-PCR approaches that allow for precise quantification of viral loads in blood, tissue, and vector samples [14].

In parallel, innovative field deployable techniques like reverse transcription-insulated isothermal polymerase chain reaction (RT-iiPCR) have shown promise for rapid on-site diagnosis. This method reduces dependencies on centralized laboratories, thereby enabling immediate decision-making, a feature highly valued during sudden outbreak events [32]. Because BTV surveillance is critical for economies reliant on livestock trade, the availability of rapid, portable techniques is further endorsed by agencies such as the Centers for Disease Control and Prevention (CDC) and WOAH.

Additionally, next-generation sequencing (NGS) approaches are being increasingly integrated into diagnostic workflows. Whole-genome sequencing not only confirms the virus’s identity but also enables real-time tracking of reassortment events, which are prevalent among BTV strains. Such genomic surveillance has been critical in differentiating between vaccine-derived strains, field isolates, and novel serotypes [27, 37]. Deep sequencing analyses complement classical assays by identifying low-frequency mutations or RNA insertions that may have implications for viral virulence and transmission dynamics.

Serological Approaches: From c-ELISA to Virus Neutralisation Assays

Serological assays are indispensable in the diagnostic landscape of BTV because they allow retrospective studies of exposure and seroprevalence assessments within livestock populations. Competitive enzyme-linked immunosorbent assays (c-ELISAs) are widely applied owing to their ability to detect BTV-specific immunoglobulin G (IgG) antibodies in both individual animals and herd populations. These tests have been useful in regions experiencing high seroprevalence, such as Mediterranean areas and parts of Asia, and are recommended by international veterinary authorities for trade and quarantine purposes [2, 40].

Virus neutralisation tests (VNTs) remain the reference method for serotype differentiation, measuring the ability of serum antibodies to neutralise live virus in vitro. However, while VNTs are highly specific, they are also labor-intensive and time-consuming, necessitating cell culture facilities and strict biosafety practices. Nonetheless, VNTs provide critical data regarding the immune status of animals following natural exposure or vaccination. Such information is vital during outbreak investigations and when assessing the efficacy of control programs [2, 39].

Complementing these assays, agar gel immunodiffusion tests provide a simpler, though less sensitive, method that can be useful particularly in resource-limited settings. Despite its lower sensitivity compared to ELISA and VNTs, it remains a cornerstone of confirmatory diagnosis in many surveillance programs worldwide.

Virus Isolation and Characterisation Techniques

Virus isolation from blood, semen, or tissue samples has traditionally been an essential diagnostic tool, despite being time-consuming and resource-demanding. Isolation in cell culture is not only used to confirm the presence of live virus but also serves as a precursor to further phenotypic and genomic analyses. The capacity to culture BTV remains fundamental for subsequent vaccine development and for assessing the virulence of unusual isolates [8, 38]. Laboratory-based techniques have evolved to effectively differentiate between direct contact transmission and vector-mediated spread, as demonstrated in studies where virus-induced cytopathic effects (CPE) in cell lines were directly compared to non-lytic budding mechanisms associated with specific viral non-structural proteins [8].

Moreover, the integration of virus isolation with whole-genome sequencing has allowed researchers to confirm serotype identity and detect novel reassortment events. For instance, when unusual serotypes such as BTV-3 and the putative BTV-29 have emerged, prompt virus isolation coupled with sequencing proved crucial in their characterisation, thereby informing containment measures and guiding vaccine design strategies [6, 27].

Integration of Diagnostic Tools into Surveillance Programs

Effective surveillance incorporates both molecular and serological techniques to monitor BTV circulation within ruminant populations and vector species, notably Culicoides midges. In regions like southern Europe and parts of the Mediterranean, coordinated efforts between diagnostic laboratories and regulatory bodies such as WOAH and the Food and Agriculture Organization (FAO) have improved the real-time monitoring of outbreaks. The combination of techniques such as RT-PCR, serology, and next-generation sequencing allows for a nuanced understanding of both current infection status and historical exposure in livestock, which in turn informs risk assessments and targeting of vector control programs [2, 13, 27].

Field deployable molecular assays against BTV have particularly added value by providing rapid screening capacity in remote or resource-constrained settings. Such approaches are aligned with recommendations from international bodies and serve to minimize trade disruptions while facilitating early intervention measures.

The intricate process of sample collection, from blood draws in symptomatic sheep to vector trapping in culicoides populations, demonstrates that an integrated diagnostic approach is essential. This multifaceted strategy not only helps in corroborating findings across different assay platforms but also provides critical epidemiological insights, such as the potential for vertical or direct contact transmission in atypical BTV strains [12, 28]. Moreover, research conducted on both asymptomatic and symptomatic infections supports the use of advanced diagnostic tools in routine surveillance and outbreak investigations, further underscoring the economic significance of maintaining robust and dynamic laboratory diagnostic capacities.

In summary, the combination of sensitive and specific molecular techniques, serological assays, virus isolation methods, and genomic approaches ensures that diagnostic laboratories are well-equipped to manage the challenges posed by an ever-evolving virus. Such comprehensive diagnostic strategies facilitate rapid outbreak identification, detailed epidemiological mapping, and the timely implementation of control strategies as advocated by regional and international animal health authorities.

Vector Biology and Transmission Dynamics in Bluetongue Virus Spread

Bluetongue virus (BTV) is a complex arbovirus whose transmission is intricately linked to the biology and ecology of its primary vectors, the Culicoides biting midges. The ability of BTV to invade new geographic regions and re‐emerge in historical areas is dependent on the vector’s innate biological characteristics, the environmental factors that govern midge behavior, and their efficiency in virus acquisition, replication, and transmission. Detailed investigations into the vector biology have unveiled multifaceted interactions that ultimately shape the spread of BTV.

Biology and Competence of Culicoides Midges

Culicoides midges, notably species such as C. imicola, C. newsteadi, and members of the Obsoletus complex, are recognized as the principal vectors transmitting BTV among ruminants [1, 34]. Their small size, high population densities, and ubiquitous presence in diverse climatic regions enable these insects to act as effective bridging agents between wildlife and domestic animals. The morphology of these vectors, including their proboscis structure, feeding behavior, and flight capacity, affords them a unique role in BTV transmission during blood meals on susceptible hosts.

Vector competence is influenced by several factors including genetic makeup of the midge and viral factors. Minute alterations in viral genome segments, particularly those encoding outer capsid proteins (VP2) or nonstructural proteins (such as NS3) that are directly involved in virus replication and egress, can dramatically affect the ability of the virus to cross the midgut infection barrier and disseminate to the salivary glands [41]. Experiments using genetic mutants of BTV have illustrated that even small deletions or point mutations in proteins involved in virus release can strongly modulate infection success in midges [41]. Additionally, interactions between viral proteins and midge cellular proteins are critical to viral replication, highlighting the complexity of vector-pathogen interplay that further influences the transmission dynamics.

Environmental Factors and Seasonal Dynamics

Environmental determinants such as temperature, humidity, altitude, and wind patterns strongly modulate vector population dynamics and, consequently, virus transmission. Climatic variables not only dictate the breeding and survival rates of Culicoides midges but also affect the incubation period of the virus within the vector. Warmer temperatures tend to shorten the extrinsic incubation period, thereby enhancing the potential for viral dissemination shortly after infection [4, 15]. Conversely, seasonal declines in temperature during the interseasonal or overwintering periods can result in low-level virus persistence within long-lived parous females or in microhabitats offering refuge [42, 43].

Recent phylogeographic models have demonstrated that BTV diffusion is associated with landscape features such as terrestrial habitat at low altitudes, wind direction, and high densities of livestock, factors which collectively create an ideal milieu for vector flight and virus dispersion [13]. In addition, the role of atmospheric conditions in long-distance midge dispersal has been underscored by studies that applied dispersion models to simulate Culicoides flight. These models confirm that wind-assisted migration can transport infected midges hundreds of kilometers, thereby linking distant outbreaks and enabling the virus to breach geographic barriers [44].

Overwintering Mechanisms and Persistence

One critical aspect in the propagation of BTV is its ability to overwinter in regions with temperate climates. Although traditional thinking posited that vertical transmission within the vector might contribute to the persistence of the virus, recent studies have provided evidence against efficient vertical transmission in Culicoides, especially with species like C. sonorensis [42]. Instead, long-term maintenance of BTV appears to involve the survival of infected adult midges that harbor the virus over the winter period [43]. The detection of viral RNA in parous females during winter months suggests that these individuals, likely infected during the previous transmission season, can serve as reservoirs to ignite new outbreaks when conditions become favorable once again.

Furthermore, the adaptability of BTV, demonstrated by its capacity to undergo genomic reassortment while circulating within vector populations, may enhance its persistence during adverse seasons [16]. Seasonal fluctuations in vector abundance, combined with viral reassortment events, can result in emergent strains that are better adapted to various climatic conditions. This evolutionary plasticity further complicates the epidemiological landscape, as observed in outbreaks where novel serotypes have appeared seemingly out of season [27, 28].

Intricate Host-Vector Interactions and Transmission Dynamics

Transmission dynamics of BTV are not solely determined by vector abundance but are also heavily influenced by host factors. The interplay between ruminant host susceptibility and vector feeding preferences creates a dynamic network where virus amplification and spillover can be rapid. Studies have shown that viral seroprevalence in cattle and small ruminants can correlate with vector distribution, highlighting cooperative epidemiological links between host density and vector activity [29, 31]. In areas with dense livestock populations paired with optimal midge habitats, BTV can spread swiftly, leading to episodic outbreaks that have significant economic implications according to international health agencies such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO).

The distinct feeding behavior of Culicoides midges, which may involve multiple feedings across several hosts, further enhances the likelihood of viral transmission. In particular, midge species exhibiting opportunistic feeding behavior can function as effective bridge vectors, facilitating interspecies transmission between wildlife reservoirs and domestic animals. This behavior also contributes to the rapid reassortment of viral strains as infected midges may harbor multiple serotypes simultaneously, thereby increasing the potential of generating novel viral genotypes with unique pathogenic properties [16, 28].

Influence of Human Activity and Global Trade

Human-mediated factors such as global livestock trade, unintentional translocation of infected vectors, and even changes in land use patterns have contributed to the expansion of BTV’s geographic footprint. Modern diagnostic and surveillance tools developed by agencies like the Centers for Disease Control and Prevention (CDC) and WHO have allowed for the rapid detection of emerging BTV serotypes, as evidenced by recent outbreaks detected in Europe [27, 28]. These methodological advances have emphasized the importance of maintaining vigilant, integrated surveillance programs that combine entomological data with clinical and virological findings to accurately model BTV transmission dynamics.

The increasing application of atmospheric dispersion models, coupled with robust molecular surveillance, now assists policymakers in anticipating the arrival and spread of particular BTV serotypes. As global climate change continues to alter the distribution of vector species, such approaches are becoming ever more pertinent to reducing the economic and animal health impacts associated with bluetongue outbreaks.

In summary, the spread of bluetongue virus is the result of a complex cascade of interactions between vector biology, environmental influences, host dynamics, and human activities. The interplay of these factors not only drives the overall epidemiology of the disease but also continually generates new challenges in its control and prevention, underscoring the need for integrated surveillance and intervention strategies endorsed by international organizations such as the CDC, WHO, and FAO [4, 13, 15].

Emerging Serotypes in Bluetongue Virus

Bluetongue virus (BTV) has long been recognized as a highly dynamic arbovirus, and recent years have unveiled a growing number of emerging serotypes that challenge traditional paradigms of virus evolution. In Europe, for example, the appearance of BTV serotype 3 in the Netherlands in September 2023, as confirmed by whole‐genome sequencing, demonstrates that serotypes previously unreported in the region can suddenly emerge and cause noticeable clinical disease in susceptible ruminants such as sheep and cattle [27]. This emergence in a region that had maintained a BT-free status underscores the unpredictable nature of viral incursions amidst global travel and climatic variations.

Simultaneously, in Western Germany an outbreak of BTV‐3 was detected in Culicoides biting midges, vectors known to facilitate the transmission of multiple serotypes, reinforcing the concept that novel BTV serotypes can be introduced into previously unaffected ecosystems via vector‐borne routes [28]. Other geographies have similarly experienced identification of atypical BTV serotypes. For instance, researchers in China have reported a putative new serotype, tentatively designated BTV‐29, isolated from asymptomatic sentinel goats with genomic characteristics distinct from known serotypes, as revealed by unique sequence identities in segment 2 (VP2) [6]. Analogous discoveries include the characterization of BTV‐28 in contaminated vaccine batches [7] and detection of BTV‐27 variants in Corsica, France, where field studies showed that the virus could be transmitted even by direct contact between goats [12]. Additionally, the first isolation of BTV‐5 in India, albeit alongside co-circulating serotypes, demonstrates that emerging serotypes are not restricted to Europe and can have profound implications for regions with diverse climatic and host species influences [45].

Molecular Underpinnings: Reassortment as an Evolutionary Force

Owing to its segmented double‐stranded RNA genome, BTV is prone to reassortment events, a process in which genome segments are exchanged between co‐infecting viral strains. This mechanism of genetic shuffling not only contributes to the diversity of emerging serotypes, but also modulates virulence, host tropism, and vector competence. Some of the most striking evidence for reassortment comes from studies in which vaccine strains and field isolates have been shown to mix their genomic segments during co‐infection in ruminants. For example, in cattle experimentally infected with a mix of vaccine strains and a virulent field isolate, a reassortant virus was isolated showing an exchanged segment 8 between BTV vaccine serotypes. This finding emphasizes that cattle, often experiencing prolonged viraemia, may serve as amplification hosts where reassortment can occur, thereby generating novel genotypic combinations [33].

Beyond isolated cases, comprehensive phylogenetic analyses of BTV full‐genome sequences across Europe have highlighted that reassortment occurs across all 10 genome segments. This process has been detected with particular frequency in areas with multiple serotypes co‐circulating concurrently. Some genomic segments, such as segment 2 (which encodes the highly variable VP2 protein responsible for serotype determination), are hot‐spots for reassortment, and may acquire variation through exchange between strains from divergent geographic origins. Notably, the reassortment between vaccine viruses and wild‐type strains has been documented repeatedly, with the genome’s plasticity facilitating the emergence of viruses potentially exhibiting altered antigenicity and fitness in specific hosts [16]. Additionally, reassortment can drive rapid virus evolution in the context of immune pressure when multiple serotypes circulate concurrently, as evidenced during outbreaks where atypical serotypes were found in co‐infections with mimicked signatures of emerging reassortant viruses [37].

Recent molecular investigations have examined the interplay between individual genome segments and host immune responses. In some instances, even small genomic changes within nonstructural proteins (such as NS3, encoded by segment 10) can drastically alter vector competence and virus release from infected cells, factors that are also modulated through reassortment [8, 41]. Coupled with these findings is the observation that reassortment is not random but appears to follow certain selective constraints. These constraints likely result from structural and functional dependencies between proteins encoded by different segments, necessitating that any exchange of genome segments must preserve critical interactions for virus replication and transmission.

Epidemiological Dynamics and Environmental Context

The epidemiological picture of BTV is continuously reshaped by the introduction of emerging serotypes and resulting reassortants. Regions with dynamic vector populations, shifting climatic conditions, and high livestock densities, such as Europe and parts of Asia, are particularly vulnerable to the incursion of novel serotypes. Monitoring efforts by international bodies like the World Organization for Animal Health (WOAH) and national public health institutions including the CDC remain crucial for early detection and response to such outbreaks, due to the considerable economic impact of bluetongue outbreaks on the livestock industry.

In the field, new BTV serotypes have been associated both with subclinical infections and, in some cases, severe clinical disease. Such variation is influenced by the specific viral constellation resulting from reassortment events, as well as the host species involved and the local vector competence. For example, the severe manifestation of BTV infection in European outbreaks of BTV-8 has been linked to multiple genomic determinants acquired through reassortment, indicating that changes in the genetic makeup can profoundly influence the clinical outcome within susceptible ruminants [18]. The fusion of genome segments from diverse origins, such as Western and Eastern topotypes, further complicates the epidemiological landscape, driving the need for continuous genomic surveillance, ideally coordinated by organizations like FAO and WOAH.

Additionally, molecular surveillance combined with robust vector monitoring strategies has enhanced our understanding of BTV transmission cycles. Not only does this facilitate rapid identification of newly emerging reassortants and serotypes, but it also aids in predicting the spread of virus variants in relation to vector distribution and climatic influences [13, 15]. The synergy between molecular virology and field epidemiology is instrumental in designing intervention strategies that can include updated vaccine compositions in regions with multiple coinfecting serotypes, thereby curtailing the potential for reassortment to generate further novel variants.

Integration of Reassortment Events in Disease Management

For public and animal health agencies such as the CDC, WHO, and WOAH, understanding the role of reassortment in generating novel serotypes of bluetongue virus is paramount. As new serotypes emerge through both direct viral evolution and reassortment events, diagnostic assays and vaccine formulations must be continuously updated to reflect the shifting genetic landscape. The insights gained from whole‐genome sequencing and in-depth phylogenetic analyses have been central to mapping these evolutionary trajectories, highlighting the necessity for integrative surveillance that blends molecular techniques with traditional epidemiological methods. In this context, reassortment is not merely an academic issue but represents a tangible challenge to livestock health, food security, and international trade.

Co-infections and Interactions: Bluetongue Virus, Schmallenberg Virus, and EHDV

Co-circulation of multiple vector‐borne viruses in ruminant populations presents a complex epidemiological scenario in which interactions between viruses can modify disease dynamics, transmission efficiency, and even host immune responses. Bluetongue virus (BTV), Schmallenberg virus (SBV), and epizootic hemorrhagic disease virus (EHDV) have overlapping ecological niches in parts of Europe, largely due to their shared reliance on Culicoides biting midges as vectors. Deep investigations into the biological interplay among these three pathogens have highlighted that their combined circulation poses significant challenges to accurate diagnosis, surveillance, and control, as emphasized by international animal health organizations such as WOAH and FAO.

Viral Ecology and Vector Interactions

In many regions of northern and western Europe, SBV is known to be enzootic, while emergent serotypes of BTV continue to be detected sporadically. For instance, studies in Western Germany have demonstrated that BTV serotype 3 was identified in pools of Culicoides biting midges at a time when SBV was already circulating widely, a scenario suggesting that the shared vector ecology may facilitate co-exposure to multiple viruses [28]. The Culicoides species involved in the transmission of these viruses have varying vector competencies that can be affected by small genetic changes within viral genome segments, thereby influencing viral replication in the midge and modulating the efficiency of transmission [41]. This interdependence raises critical questions regarding whether the presence of one virus might affect the acquisition, retention, or transmission efficiency of another during the blood meal of a single midge. The detection of multiple viral RNAs in field-collected midges indicates that mixed infections are not only possible but could potentially alter the inter-segment dynamics within the arthropod vector, a subject that demands further mechanistic studies to elucidate the potential for mutual interference or synergism during co-infection at the vector level.

Host Co-infection Dynamics and Immune Modulation

When considering the mammalian host as an environment for co-infection, both the innate immune response and specific viral factors play substantial roles. BTV, for example, expresses non-structural proteins such as NS4 that act as interferon antagonists, thereby dampening the host antiviral response and potentially enabling simultaneous infection with other viruses, including SBV and EHDV [23]. Although investigations in certain ruminant populations, such as cattle and water buffalo in southern Italy, have indicated that exposure to SBV did not necessarily predispose animals to become seropositive for BTV [29], the possibility remains that subclinical or sequential infections may modulate the overall disease presentation and affect the serological profiles detected during outbreak investigations. The immunological interplay in co‐infected animals can lead to altered cytokine responses, modulation of interferon-stimulated gene expression, and potential interference in the viral cycle, which may either exacerbate clinical disease or lead to atypical pathogen shedding profiles. This phenomenon is particularly concerning for economically critical livestock industries, and it has been repeatedly underscored by agencies such as the CDC and WHO when developing guidelines for vector-borne disease surveillance.

Epidemiological Implications and Field Observations

Field data from recent European outbreaks underscore the critical importance of considering co-infections in epidemiological models and surveillance systems. An extraordinary study in France documented the simultaneous circulation of a novel BTV-8 strain alongside the first introduction of EHDV-8, a development that raises concerns about the risk of viral reassortment and the emergence of novel strains with unpredictable virulence profiles [37]. The co-circulation of these viruses in regions with high livestock density necessitates refined molecular diagnostic methods to differentiate between pathogens, as serological cross-reactions or concurrent infections could mask the detection of emerging serotypes.

Additionally, epidemiological investigations in Spain, France, and Germany have demonstrated that co-infections can complicate the clinical picture in ruminants, where distinct viruses might induce overlapping symptoms such as fever, hemorrhagic manifestations, and reduced productivity. Experimental studies have shown that co-infection does not always lead to additive pathogenicity; in some cases, one virus’s immune evasion strategy may indirectly suppress the replication of a second virus, leading to mixed infection profiles that challenge both field diagnostics and molecular characterization efforts. The integration of high-resolution whole-genome sequencing methods in recent studies facilitates the detection of subtle reassortment events, especially when vaccine strains with attenuated phenotypes might interact with field strains, potentially altering the overall virulence landscape [16, 33].

Surveillance, Control, and Policy Considerations

From a public and animal health perspective, robust surveillance protocols are indispensable when dealing with co-infections among BTV, SBV, and EHDV. International bodies such as WOAH and FAO advocate for integrated vector management strategies and enhanced molecular surveillance to better predict incursion events. For example, rapid diagnostic assays, including multiplex RT-PCR techniques, allow for the detection of these viruses in blood, tissue, and vector pools. Such tools are critical in implementing swift movement restrictions and targeted vaccination campaigns, thereby reducing the economic impact on livestock industries, as highlighted by several studies [27, 32]. Moreover, a proactive approach to vaccine development, as seen with the advent of recombinant vaccines and synthetic biology platforms, may prove vital in producing cross-protective immunogens that can preemptively address the threat posed by co-circulating viruses [22, 38].

In light of climate change and shifting vector distributions, outbreaks involving multiple arboviruses are likely to become more frequent. Thus, understanding the underlying mechanisms that govern co-infections and virus–virus interactions is not merely an academic exercise but is central to designing future-proof control strategies. These strategies should factor in the potential for altered vector competence and changing epidemiological patterns, integrating both the local dynamics of virus transmission in regions with high ruminant densities and the global epidemiological frameworks set forth by health authorities.

This comprehensive understanding of virus interactions and co-infection dynamics underscores the need for continuous monitoring, advanced diagnostic approaches, and international collaboration in managing these economically significant diseases.

Prevention, Control Measures, and Future Prospects in Bluetongue Virus Management

Bluetongue virus (BTV) continues to impose significant economic burdens on livestock industries worldwide, necessitating an integrated approach combining vector management, vaccination, and advanced diagnostics. Given the virus’s segmented genome that predisposes it to reassortment events [16], as well as its rapid spread modulated by climatic factors [15] and midge biology [34], prevention and control measures must address multiple facets of the transmission cycle. The following section provides an in‐depth analysis of current strategies and emerging approaches that are shaping BTV management.

Vaccination and Immunization Strategies

Vaccination remains the cornerstone of bluetongue virus prevention, as mass immunization directly reduces both clinical disease and virus circulation. Traditional vaccine formulations, including inactivated and live-attenuated vaccines, have been utilized across various regions to curtail outbreaks; however, their limitations are well documented. Live-attenuated vaccines, while providing robust immunity, carry risks of vaccine reversion or genomic reassortment with field strains, as demonstrated by the occurrence of reassortant viruses in cattle [33] and multiple segments being implicated in virulence [18]. Furthermore, concerns about safety and the potential for transplacental infection [2] have driven the search for next-generation vaccines. In recent years, recombinant viral vector vaccines and synthetic biology approaches have advanced significantly, offering DIVA (differentiation of infected from vaccinated animals) capabilities essential for surveillance programs endorsed by organizations such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) [10, 38]. Notably, disabled infectious single-cycle (DISC) vaccines [46] have shown promise in providing cross-protective immunity across multiple serotypes, which is particularly relevant given the expanding global distribution and emergence of novel serotypes such as BTV‐3 in Europe [27] and BTV‐29 in China [6]. Additionally, synthetic chimeric vaccine constructs, which incorporate epitope regions of different serotypes, represent a forward-looking approach capable of rapid deployment in response to emergent viral variants [22].

Vector Control and Surveillance

The transmission of BTV is intrinsically linked to the biology of Culicoides biting midges. Effective control measures incorporate targeting the vector to reduce virus circulation. Physical interventions such as insecticide spraying and strategic deployment of dip solutions in livestock are conventional yet effective practices demonstrated to depress virus prevalence; studies have confirmed that routine insecticide application reduces infection odds substantially [47]. However, understanding species-specific roles, particularly of Culicoides imicola and members of the Newsteadi complex, informs targeted control strategies that enhance efficacy [34]. Surveillance systems employing both entomological monitoring and serologic assessments have been emphasized by the Centers for Disease Control and Prevention (CDC) as critical components in managing vector-borne diseases. In parallel, innovative diagnostic assays, such as portable reverse transcription insulated isothermal polymerase chain reaction (RT-iiPCR) tests, offer field-deployable options with high sensitivity and rapid turnaround, which are essential for early intervention during outbreaks [32]. These methods bolster integrated surveillance programs recommended by the World Health Organization (WHO) for diseases of economic significance, even though BTV is not a zoonotic threat.

Advanced Diagnostic and Genomic Approaches

Rapid and precise identification of circulating serotypes is vital to effective BTV management. The polythetic nature of BTV, with serotype-specific variations largely determined by the VP2 protein [14], necessitates subtype-specific detection methods that are adaptable to emerging viral strains. Recent advances using real-time RT-PCR and next-generation sequencing (NGS) technologies have enhanced the molecular epidemiology of BTV, enabling detection of novel serotypes as reported in diverse regions, such as the identification of BTV-3 in Western Germany [28] and the surveillance-enabled emergence of atypical strains in France [37]. These techniques not only support timely outbreak response but also facilitate assessments of reassortment dynamics [16] and genetic evolution that directly inform vaccine design and vector control measures. Molecular diagnostics, endorsed by international bodies like WOAH, are integral to designing surveillance networks that monitor virus evolution and spread under changing climatic and ecological conditions.

Integrated Farm Management and International Cooperation

An integrated approach to BTV management is critical, merging vaccination, vector control, and enhanced diagnostic capabilities. Livestock management practices must adapt to diverse ecological and climatic zones, particularly given that factors such as average temperature and altitude can influence Culicoides abundance and BTV movement [13]. Farm-level biosecurity, coupled with coordinated regional surveillance, minimizes the risk of virus spread during vector active periods. International collaboration, facilitated by entities such as the FAO and WOAH, is paramount for developing standardized control measures and sharing epidemiological data. Such cooperation is especially important in regions experiencing recurrent or novel BTV incursions. For instance, cross-border monitoring in Europe and Africa has provided insight into transmission routes and reservoir populations, aiding in the design of targeted interventions underpinned by robust epidemiological models [13].

Future Prospects in BTV Management

Looking forward, the landscape of BTV management is likely to benefit from innovations in vaccine technology, diagnostic platforms, and ecological modeling. The development of synthetic vaccine platforms offers a transformative approach that greatly reduces the lag time from viral discovery to mass immunization, thereby aligning with rapid response strategies recommended by global health authorities such as the CDC and WHO [22]. Coupled with advances in molecular surveillance and vector ecology, future control strategies will likely integrate real-time data analytics to predict outbreak hotspots based on changes in climatic patterns and midge population dynamics, a critical capability in the context of global climate change [15].

Moreover, research aimed at understanding the molecular mechanisms of virus-host and virus-vector interactions, including the role of nonstructural proteins in virus release and immune modulation [8, 11], promises to uncover novel targets for antiviral therapies. Selective breeding programs aimed at enhancing resistance in ruminant livestock, combined with precision diagnostics, may further modulate disease impact. Through multidisciplinary approaches involving virology, entomology, bioinformatics, and veterinary sciences, future prospects for BTV management lean heavily on the integration of innovative technologies and international policy frameworks to mitigate economic losses and enhance livestock health.

By situating current control measures and future innovations within a robust framework of integrated surveillance, vaccination, and vector control, the blueprint for effective BTV management emerges as a dynamic and multifaceted endeavor highly relevant to veterinary health authorities worldwide.

References

[1] Subhadra S, Sreenivasulu D, Pattnaik R, Panda B, Kumar S. Bluetongue virus: Past, present, and future scope.. Journal of Infection in Developing Countries. 2023. DOI: https://doi.org/10.3855/jidc.16947

[2] Saminathan M, Singh KP, Khorajiya J, Dinesh M, Vineetha S, Maity M, et al.. An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India. Veterinary Quarterly. 2020. DOI: https://doi.org/10.1080/01652176.2020.1831708

[3] . bluetongue virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.91520

[4] Mayo C, McDermott E, Kopanke J, Stenglein M, Lee JS, Mathiason C, et al.. Ecological Dynamics Impacting Bluetongue Virus Transmission in North America. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/fvets.2020.00186

[5] Alkhamis M, Aguilar-Vega C, Fountain‐Jones N, Lin K, Perez A, Sánchez-Vizcaíno J. Global emergence and evolutionary dynamics of bluetongue virus. Scientific Reports. 2020. DOI: https://doi.org/10.1038/s41598-020-78673-9

[6] Yang H, Gu W, Li Z, Zhang L, Liao D, Song J, et al.. Novel Putative Bluetongue Virus Serotype 29 Isolated from Inapparently Infected Goat in Xinjiang of China.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13927

[7] Bumbarov V, Golender N, Jenckel M, Wernike K, Beer M, Khinich E, et al.. Characterization of bluetongue virus serotype 28.. Transboundary and Emerging Diseases. 2019. DOI: https://doi.org/10.1111/tbed.13338

[8] Labadie T, Sullivan E, Roy P. Multiple Routes of Bluetongue Virus Egress. Microorganisms. 2020. DOI: https://doi.org/10.3390/microorganisms8070965

[9] He Y, Shivakoti S, Ding K, Cui Y, Roy P, Zhou ZH. In situ structures of RNA-dependent RNA polymerase inside bluetongue virus before and after uncoating. Proceedings of the National Academy of Sciences of the United States of America. 2019. DOI: https://doi.org/10.1073/pnas.1905849116

[10] Ranjan K, Prasad M, Brar B, Lambe U, Kumar R, Ghosh M, et al.. Bluetongue virus vaccine: conventional to modern approach.. Acta virologica. 2019. DOI: https://doi.org/10.4149/av_2019_109

[11] Mohl B, Roy P. Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00898-19

[12] Bréard E, Schulz C, Sailleau C, Bernelin-Cottet C, Viarouge C, Vitour D, et al.. Bluetongue virus serotype 27: Experimental infection of goats, sheep and cattle with three BTV-27 variants reveal atypical characteristics and likely direct contact transmission BTV-27 between goats.. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12780

[13] Jacquot M, Nomikou K, Palmarini M, Mertens PR, Biek R. Bluetongue virus spread in Europe is a consequence of climatic, landscape and vertebrate host factors as revealed by phylogeographic inference. Proceedings of the Royal Society B: Biological Sciences. 2017. DOI: https://doi.org/10.1098/rspb.2017.0919

[14] Maan S, Maan N, Belaganahalli M, Potgieter AC, Kumar V, Batra K, et al.. Development and Evaluation of Real Time RT-PCR Assays for Detection and Typing of Bluetongue Virus. PLoS ONE. 2016. DOI: https://doi.org/10.1371/journal.pone.0163014

[15] Samy A, Samy A, Peterson A. Climate Change Influences on the Global Potential Distribution of Bluetongue Virus. PLoS ONE. 2016. DOI: https://doi.org/10.1371/journal.pone.0150489

[16] Nomikou K, Hughes J, Wash R, Kellam P, Bréard E, Zientara S, et al.. Widespread Reassortment Shapes the Evolution and Epidemiology of Bluetongue Virus following European Invasion. PLoS Pathogens. 2015. DOI: https://doi.org/10.1371/journal.ppat.1005056

[17] Jenckel M, Bréard E, Schulz C, Sailleau C, Viarouge C, Hoffmann B, et al.. Complete Coding Genome Sequence of Putative Novel Bluetongue Virus Serotype 27. Genome Announcements. 2015. DOI: https://doi.org/10.1128/genomeA.00016-15

[18] Janowicz A, Caporale M, Shaw A, Gulletta S, Gialleonardo LD, Ratinier M, et al.. Multiple Genome Segments Determine Virulence of Bluetongue Virus Serotype 8. Journal of Virology. 2015. DOI: https://doi.org/10.1128/JVI.00395-15

[19] Leeuw ID, Garigliany M, Bertels G, Willems T, Desmecht D, Clercq K. Bluetongue virus RNA detection by real-time rt-PCR in post-vaccination samples from cattle.. Transboundary and Emerging Diseases. 2015. DOI: https://doi.org/10.1111/tbed.12100

[20] Batten C, Darpel K, Henstock M, Fay P, Veronesi E, Gubbins S, et al.. Evidence for Transmission of Bluetongue Virus Serotype 26 through Direct Contact. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0096049

[21] Calvo-Pinilla E, Castillo-Olivares J, Jabbar T, Ortego J, Poza Fdl, Marín-López A. Recombinant vaccines against bluetongue virus.. Virus Research. 2014. DOI: https://doi.org/10.1016/j.virusres.2013.11.013

[22] Nunes SF, Hamers C, Ratinier M, Shaw A, Brunet S, Hudelet P, et al.. A Synthetic Biology Approach for a Vaccine Platform against Known and Newly Emerging Serotypes of Bluetongue Virus. Journal of Virology. 2014. DOI: https://doi.org/10.1128/JVI.02183-14

[23] Ratinier M, Shaw A, Barry G, Gu Q, Gialleonardo LD, Janowicz A, et al.. Bluetongue Virus NS4 Protein Is an Interferon Antagonist and a Determinant of Virus Virulence. Journal of Virology. 2016. DOI: https://doi.org/10.1128/JVI.00422-16

[24] Stewart ME, Hardy A, Barry G, Pinto R, Caporale M, Melzi E, et al.. Characterization of a second open reading frame in genome segment 10 of bluetongue virus. Journal of General Virology. 2015. DOI: https://doi.org/10.1099/jgv.0.000267

[25] Sung P, Roy P. Sequential packaging of RNA genomic segments during the assembly of Bluetongue virus. Nucleic Acids Research. 2014. DOI: https://doi.org/10.1093/nar/gku1171

[26] Feenstra F, Gennip RGv, Water SVDvd, Rijn PVv. RNA Elements in Open Reading Frames of the Bluetongue Virus Genome Are Essential for Virus Replication. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0092377

[27] Holwerda M, Santman-Berends I, Harders F, Engelsma M, Vloet R, Dijkstra E, et al.. Emergence of Bluetongue Virus Serotype 3, the Netherlands, September 2023. Emerging Infectious Diseases. 2024. DOI: https://doi.org/10.3201/eid3008.231331

[28] Voigt A, Kampen H, Heuser E, Zeiske S, Hoffmann B, Höper D, et al.. Bluetongue Virus Serotype 3 and Schmallenberg Virus in Culicoides Biting Midges, Western Germany, 2023. Emerging Infectious Diseases. 2024. DOI: https://doi.org/10.3201/eid3007.240275

[29] Ferrara G, Improda E, Piscopo F, Esposito R, Iovane G, Pagnini U, et al.. Bluetongue virus seroprevalence and risk factor analysis in cattle and water buffalo in southern Italy (Campania region). Veterinary research communications. 2023. DOI: https://doi.org/10.1007/s11259-023-10215-w

[30] Gong Q, Wang Q, Yang X, Li D, Zhao B, Ge G, et al.. Seroprevalence and Risk Factors of the Bluetongue Virus in Cattle in China From 1988 to 2019: A Comprehensive Literature Review and Meta-Analysis. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2020.550381

[31] Liu F, Gong Q, Zhang R, Chen Z, Wang Q, Sun Y, et al.. Prevalence and risk factors of bluetongue virus infection in sheep and goats in China: A systematic review and meta-analysis.. Microbial Pathogenesis. 2021. DOI: https://doi.org/10.1016/j.micpath.2021.105170

[32] Ambagala A, Pahari S, Fisher M, Lee PA, Pasick J, Ostlund EN, et al.. A Rapid Field‐Deployable Reverse Transcription‐Insulated Isothermal Polymerase Chain Reaction Assay for Sensitive and Specific Detection of Bluetongue Virus. Transboundary and Emerging Diseases. 2017. DOI: https://doi.org/10.1111/tbed.12388

[33] Bergh Cvd, Coetzee P, Venter E. Reassortment of bluetongue virus vaccine serotypes in cattle. Journal of the South African Veterinary Association. 2018. DOI: https://doi.org/10.4102/jsava.v89i0.1649

[34] Foxi C, Delrio G, Falchi G, Marche MG, Satta G, Ruiu L. Role of different Culicoides vectors (Diptera: Ceratopogonidae) in bluetongue virus transmission and overwintering in Sardinia (Italy). Parasites & Vectors. 2016. DOI: https://doi.org/10.1186/s13071-016-1733-9

[35] Legisa D, Gonzalez F, Santos MDD. Bluetongue virus in South America, Central America and the Caribbean.. Virus Research. 2014. DOI: https://doi.org/10.1016/j.virusres.2013.10.030

[36] Maclachlan N, Wilson WC, Crossley B, Mayo C, Jasperson D, Breitmeyer R, et al.. Novel Serotype of Bluetongue Virus, Western North America. Emerging Infectious Diseases. 2013. DOI: https://doi.org/10.3201/eid1904.120347

[37] Gondard M, Postic L, Garin E, Turpaud M, Vorimore F, Ngwa-Mbot D, et al.. Exceptional Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) circulation in France in 2023. Virus Research. 2024. DOI: https://doi.org/10.1016/j.virusres.2024.199489

[38] Jiménez-Cabello L, Utrilla-Trigo S, Calvo-Pinilla E, Moreno S, Nogales A, Ortego J, et al.. Viral Vector Vaccines against Bluetongue Virus. Microorganisms. 2020. DOI: https://doi.org/10.3390/microorganisms9010042

[39] Rojas J, Rodríguez-Martín D, Martín V, Sevilla N. Diagnosing bluetongue virus in domestic ruminants: current perspectives. Veterinary medicine. 2019. DOI: https://doi.org/10.2147/VMRR.S163804

[40] Yilma M, Mekonnen M. Competitive Enzyme Linked Immuno-Sorbent Assay (c-ELISA) Based Sero-Prevalence of Bluetongue Virus (BTV) on Small Ruminants in SelectedAreas of Wolyita, Southern Ethiopia. Virology & Mycology. 2015. DOI: https://doi.org/10.4172/2161-0517.1000148

[41] Gennip RGv, Drolet B, Lopez PR, Roost A, Boonstra J, Rijn PVv. Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus. Parasites & Vectors. 2019. DOI: https://doi.org/10.1186/s13071-019-3722-2

[42] Osborne C, Mayo C, Mullens B, McDermott E, Gerry A, Reisen W, et al.. Lack of Evidence for Laboratory and Natural Vertical Transmission of Bluetongue Virus in Culicoides sonorensis (Diptera: Ceratopogonidae). Journal of medical entomology. 2015. DOI: https://doi.org/10.1093/jme/tju063

[43] Mayo C, Mullens B, Reisen W, Osborne C, Gibbs E, Gardner IA, et al.. Seasonal and Interseasonal Dynamics of Bluetongue Virus Infection of Dairy Cattle and Culicoides sonorensis Midges in Northern California – Implications for Virus Overwintering in Temperate Zones. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0106975

[44] Burgin L, Burgin L, Gloster J, Sanders C, Mellor PS, Gubbins S, et al.. Investigating incursions of bluetongue virus using a model of long-distance Culicoides biting midge dispersal.. Transboundary and Emerging Diseases. 2013. DOI: https://doi.org/10.1111/j.1865-1682.2012.01345.x

[45] Hemadri D, Maan S, Chanda MM, Rao P, Putty K, Krishnajyothi Y, et al.. Dual Infection with Bluetongue Virus Serotypes and First‐Time Isolation of Serotype 5 in India. Transboundary and Emerging Diseases. 2017. DOI: https://doi.org/10.1111/tbed.12589

[46] Celma C, Stewart ME, Wernike K, Eschbaumer M, González-Molleda L, Bréard E, et al.. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines. Journal of Virology. 2016. DOI: https://doi.org/10.1128/JVI.01892-16

[47] Adam I, Abdalla MA, Mohamed MEH, Aradaib I. Prevalence of bluetongue virus infection and associated risk factors among cattle in North Kordufan State, Western Sudan. BMC Veterinary Research. 2014. DOI: https://doi.org/10.1186/1746-6148-10-94